PATENT CLAIM ANALYSIS

Application Number: 15777147
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["435", "006100"]

Abstract:
Various embodiments include methods of diagnosing susceptibility to epilepsy in an individual or methods of managing treatment of a neurological condition in an individual, comprising: obtaining a sample from the individual; assaying the sample to determine the presence or absence of one or more biomarkers of epilepsy; and diagnosing susceptibility to epilepsy in the individual based on the presence of one or more biomarkers of epilepsy. Various embodiments further include kits for diagnostic use, comprising a diagnostic panel of one or more of the biomarkers: Let-7d-5p, miR-340-3p, miR-484, miR-151, miR-350, miR-770-5p, miR-139-3p, miR-2985, miR-101a-5p, miR-206-3p, miR-760-3p, miR-383-5p, miR-294, and miR-328a-5p.

Claim (Index 19):
The method of  claim 1 , wherein the detected fluorescent signals is at least 8-fold higher than a fluorescent signal generated in a negative control sample which has an absence of biomarkers of epilepsy.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 93.0
- Lexical Diversity: 2.12281
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15852128', '15125714', '15243604', '14873385', '13735760']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.4241580694552271
- 35 USC 102 Novelty (BERT): 0.5221810695225246
- Combined Prediction Score: 0.4339603694619569
- Mean Citation Score: 273.42167800000004
- Max Citation Score: 280.81384
- Similarity Product: 155.42630852600576

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test